APA (7th ed.) Citation

Weiß, C., Becker, L., Friese, J., Blaschek, A., Hahn, A., Illsinger, S., . . . Ziegler, A. (2024). Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: A population-based observational study. The lancet. Regional health, 47, . https://doi.org/10.1016/j.lanepe.2024.101092

Chicago Style (17th ed.) Citation

Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational Study." The Lancet. Regional Health 47 (2024). https://doi.org/10.1016/j.lanepe.2024.101092.

MLA (9th ed.) Citation

Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational Study." The Lancet. Regional Health, vol. 47, 2024, https://doi.org/10.1016/j.lanepe.2024.101092.